Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Awasthi

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Communications Biology|September 13, 2023
Omicron sub-lineage BA.5 infection results in attenuated pathology in hACE2 transgenic miceZaigham Abbas Rizvi, Jyotsna Dandotiya, Srikanth Sadhu, et al.
Antiviral Research|November 10, 2023
Fangchinoline inhibits SARS-CoV-2 and MERS-CoV entrySrikanth Sadhu, Jyotsna Dandotiya, Rajdeep Dalal, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 26, 2025
First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory/antiviral agentRaghavendra S Patwardhan, Zaigham Abbas Rizvi, Vikram Gota, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 26, 2024
Coconut Water Induces Clinical Remission in Mild to Moderate Ulcerative Colitis: Double-blind Placebo-controlled TrialSaurabh Kedia, Shubi Virmani, Aditya Bajaj, et al.
Vaccine|November 3, 2022
Safety, tolerability and immunogenicity of Biological E's CORBEVAX™ vaccine in children and adolescents: A prospective, randomised, double-blind, placebo controlled, phase-2/3 studySubhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, et al.
Human Vaccines & Immunotherapeutics|April 28, 2023
Immunogenicity and safety of Biological E's CORBEVAX™ vaccine compared to COVISHIELD™ (ChAdOx1 nCoV-19) vaccine studied in a phase-3, single blind, multicentre, randomized clinical trialSubhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, et al.
Cell Reports|November 25, 2020
An IL-27-Driven Transcriptional Network Identifies Regulators of IL-10 Expression across T Helper Cell SubsetsHuiyuan Zhang, Asaf Madi, Nir Yosef, et al.
Iscience|March 16, 2021
Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluationBrunda Ganneru, Harsh Jogdand, Vijaya Kumar Daram, et al.
Nature|March 8, 2013
Dynamic regulatory network controlling TH17 cell differentiationNir Yosef, Alex K Shalek, Jellert T Gaublomme, et al.
Frontiers in Immunology|February 6, 2025
CoviWall, a whole-virion-inactivated B.1.617.2 vaccine candidate, induces potent humoral and Th1 cell response in mice and protects against B.1.617.2 strain challenge in Syrian hamstersJyotsna Dandotiya, Neeta Adhikari, Manas Ranjan Tripathy, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Communications Biology|September 13, 2023
Omicron sub-lineage BA.5 infection results in attenuated pathology in hACE2 transgenic miceZaigham Abbas Rizvi, Jyotsna Dandotiya, Srikanth Sadhu, et al.
Antiviral Research|November 10, 2023
Fangchinoline inhibits SARS-CoV-2 and MERS-CoV entrySrikanth Sadhu, Jyotsna Dandotiya, Rajdeep Dalal, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 26, 2025
First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory/antiviral agentRaghavendra S Patwardhan, Zaigham Abbas Rizvi, Vikram Gota, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 26, 2024
Coconut Water Induces Clinical Remission in Mild to Moderate Ulcerative Colitis: Double-blind Placebo-controlled TrialSaurabh Kedia, Shubi Virmani, Aditya Bajaj, et al.
Vaccine|November 3, 2022
Safety, tolerability and immunogenicity of Biological E's CORBEVAX™ vaccine in children and adolescents: A prospective, randomised, double-blind, placebo controlled, phase-2/3 studySubhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, et al.
Human Vaccines & Immunotherapeutics|April 28, 2023
Immunogenicity and safety of Biological E's CORBEVAX™ vaccine compared to COVISHIELD™ (ChAdOx1 nCoV-19) vaccine studied in a phase-3, single blind, multicentre, randomized clinical trialSubhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, et al.
Cell Reports|November 25, 2020
An IL-27-Driven Transcriptional Network Identifies Regulators of IL-10 Expression across T Helper Cell SubsetsHuiyuan Zhang, Asaf Madi, Nir Yosef, et al.
Iscience|March 16, 2021
Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluationBrunda Ganneru, Harsh Jogdand, Vijaya Kumar Daram, et al.
Nature|March 8, 2013
Dynamic regulatory network controlling TH17 cell differentiationNir Yosef, Alex K Shalek, Jellert T Gaublomme, et al.
Frontiers in Immunology|February 6, 2025
CoviWall, a whole-virion-inactivated B.1.617.2 vaccine candidate, induces potent humoral and Th1 cell response in mice and protects against B.1.617.2 strain challenge in Syrian hamstersJyotsna Dandotiya, Neeta Adhikari, Manas Ranjan Tripathy, et al.
Pageof 13